Mustang Bio Inc (MBIO)

NASDAQ
Currency in USD
1.410
+0.010(+0.71%)
Closed
After Hours
1.400-0.010(-0.709%)
MBIO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
Fair Value
Day's Range
1.3501.470
52 wk Range
1.35067.000
Key Statistics
Edit
Prev. Close
1.41
Open
1.41
Day's Range
1.35-1.47
52 wk Range
1.35-67
Volume
57.59K
Average Volume (3m)
338.17K
1-Year Change
-97.03%
Book Value / Share
-5.51
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MBIO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

Mustang Bio Company Profile

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-117 and MB-217, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-101 CAR T cell program for glioblastoma; MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children’s Hospital, CSL Behring; Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH. The company was incorporated in 2015 and is headquartered in Waltham, Massachusetts. Avenue Mustang Bio, Inc. is a subsidiary of Fortress Biotech, Inc.

Compare MBIO to Peers and Sector

Metrics to compare
MBIO
Peers
Sector
Relationship
P/E Ratio
−0.3x−1.4x−0.5x
PEG Ratio
0.00−0.060.00
Price/Book
−0.8x1.0x2.6x
Price / LTM Sales
-17.3x3.0x
Upside (Analyst Target)
-318.0%56.4%
Fair Value Upside
Unlock15.3%9.9%Unlock

Earnings

Latest Release
May 12, 2023
EPS / Forecast
-2.06 / -3.01
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Mustang Bio (MBIO) Stock Price Today?

The Mustang Bio stock price today is 1.41.

What Stock Exchange Does Mustang Bio Trade On?

Mustang Bio is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Mustang Bio?

The stock symbol for Mustang Bio is "MBIO."

What Is the Mustang Bio Market Cap?

As of today, Mustang Bio market cap is 6.76M.

What is Mustang Bio Earnings Per Share?

The Mustang Bio EPS is -57.54.

From a Technical Analysis Perspective, Is MBIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.